Bristol-Myers Squibb gains approval for arthritis drug
Orencia (abatacept) from Bristol-Myers Squibb gained U.S. regulatory approval for treating rheumatoid arthritis (RA).
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.